OR WAIT null SECS
December 07, 2017
The company is expanding its 380,000-square-feet Molex Little Rock facility to include a FDA-registered manufacturing center of excellence for connected health and drug-delivery devices.
December 02, 2017
Softgel capsules are a popular dosage form among patients but they also provide a number of manufacturing benefits over liquid-filled hardgel capsules.
Modified-release lipid-based formulations in softgel capsules can address physiochemical and pharmacokinetic challenges posed by drug compounds.
November 14, 2017
ADC Bio experts warn of impending problems in the ADC pipeline with millions wasted in development costs.
November 10, 2017
The authors of the study believe it could have significant implications for the discovery of new dermatological products for major diseases such as psoriasis.
November 02, 2017
Ralph Gosden, head of product development at Catalent’s Swindon, United Kingdom site, explains the opportunities of orally disintegrating tablets as a patient-centric dosage form.
Pharmaceutical companies are increasingly adopting patient-centric formulation development to ensure that drug products adequately meet the needs of end-users in all target patient populations.
Model-based formulation and technology selection methodologies facilitate rapid product development.
October 16, 2017
Through the support of the Japanese agency, Daiichi Sankyo intends to further develop its genetic vaccine platform focused around its new nucleic acid delivery technology.
Dow’s portfolio of solutions for pharmaceutical applications now includes products from Dow Corning’s silicone technology platform.